In the realm of synthetic peptides, MT-1 (Melanotan I / Afamelanotide) and PT-141 (Bremelanotide, MC4R agonist) are two compounds that have gained attention for their distinct yet related mechanisms of action. Both peptides are derived from the alpha-melanocyte-stimulating hormone (α-MSH) and have been studied for their effects on pigmentation, sexual function, and appetite regulation. This article aims to provide a neutral, factual comparison of these two peptides based on their class, mechanism, documented benefits, administration protocols, and associated risks.
| MT-1 (Melanotan I / Afamelanotide) | PT-141 (Bremelanotide, MC4R agonist) | |
|---|---|---|
| Drug class | Synthetic peptide analog of α-MSH | Synthetic peptide, MC4R agonist |
| Mechanism | Stimulates melanocytes to produce melanin | Mimics effects of α-MSH, targeting MC4R for sexual function and appetite suppression |
| Primary use | Tanning, treating photosensitivity disorders | Sexual dysfunction, potential weight management |
| Administration | SC dose range 2-20 mg, 2-3 times per week | SC/IM dose range 1.25-8 mg, as needed or weekly |
| Evidence strength | General knowledge benefits, off-label use | Research-documented benefits, investigational use |
| Side effects | Nausea, yawning, potential blood pressure changes | Nausea, headache, injection site reactions |
Mechanism and Class
MT-1 (Melanotan I / Afamelanotide) is a synthetic peptide analog of α-MSH, designed to stimulate melanocytes to produce melanin, the pigment responsible for skin color [6]. This mechanism provides a natural defense against ultraviolet (UV) radiation. In contrast, PT-141 (Bremelanotide, MC4R agonist) is a synthetic peptide that acts as a melanocortin-4 receptor (MC4R) agonist, mimicking the effects of α-MSH and targeting MC4R to stimulate neural pathways involved in sexual function and appetite suppression [34].
Primary Uses
The primary use of MT-1 is for inducing skin pigmentation (tanning) via melanogenesis, which increases the skin's natural protection against UV radiation, reducing the risk of sunburn and potentially decreasing the risk of skin cancer [6]. It has also been used off-label to treat conditions such as erythropoietic protoporphyria, a photosensitivity disorder, by reducing the severity of phototoxic reactions to sunlight [10]. On the other hand, PT-141 has been shown to increase sexual desire and arousal in both men and women, particularly in those with sexual dysfunction [34]. It has been studied for its potential use in treating conditions like hypoactive sexual desire disorder (HSDD) and erectile dysfunction (ED) [34]. Additionally, the peptide may have an impact on energy balance and food intake, potentially contributing to weight management when used in conjunction with a healthy diet and lifestyle [11].
Administration
The typical injectable protocol for MT-1 involves an adult human subcutaneous (SC) dose range of 2 mg to 20 mg, administered 2 to 3 times per week, with the cycle length varying based on the individual's response and desired level of pigmentation. For PT-141, the research-only adult human SC or intramuscular (IM) dose range is typically 1.25 mg to 8 mg, administered as needed or on a weekly basis, depending on the individual's response and therapeutic goal.
Side Effects and Contraindications
Both peptides have similar side effects, including nausea, with MT-1 potentially causing yawning and changes in blood pressure, while PT-141 may cause headaches and injection site reactions. Both are contraindicated in individuals with a history of melanoma or other melanocortin receptor-related cancers and are not recommended for individuals with uncontrolled hypertension or cardiovascular disease due to potential blood pressure effects.
References
- Cosmetic Dermatology_ Products and Procedures
- Endocrinology_ Adult and Pediatric
- GPCRs_ From Deorphanization to Lead Structure Identification
- Handbook of Biologically Active Peptides
- Hypothalamic Integration of Energy Metabolism
- Kosmetik für Ärzte und Apotheker
- Life Force
- Living a Fully Optimized Life
- Mechanisms of Photoaging and Cutaneous Photocarcinogenesis
- Peptide Protocols Volume One — William A Seeds MD
- Peptide Therapeutics_ Design and Development
- Peptide and Protein Design for Biopharmaceutical Applications
- Peptides_ Chemistry and Biology, 2nd Edition
- Pharmacology
- Photoimmunology of Langerhans cells
- The Perricone Prescription
- The Pineal and its Hormones
- Therapeutic Peptides and Proteins Formulation, Processing — Ajay K Banga
- Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
- α-MSH related peptides_ a new class of anti-inflammatory and immunomodulating drugs